| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |